Operating cash flow decreased 12.0%
Operating cash flow changed -12.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$246.2M→$216.6M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MEDP financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 163 bp higher
Operating margin changed +163 basis points from the comparable as-filed period.
21.49%→23.12%2 prior comparisons
Revenue increased 8.5%
Revenue changed +8.5% from the comparable as-filed period.
$659.9M→$716.0M2 prior comparisons
Current liabilities increased 16.5%
Current liabilities changed +16.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.3B→$1.5B4 prior comparisons
Operating cash-flow margin moved 706 bp lower
Operating cash-flow margin changed -706 basis points from the comparable as-filed period.
37.31%→30.25%2 prior comparisons
Current ratio increased 44.9%
Current ratio changed +44.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
0.57→0.834 prior comparisons
Free-cash-flow margin moved 825 bp lower
Free-cash-flow margin changed -825 basis points from the comparable as-filed period.
35.69%→27.44%2 prior comparisons
Capex / revenue moved 119 bp higher
Capex / revenue changed +119 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.62%→2.82%2 prior comparisons
Stock-based compensation increased 20.3%
Stock-based compensation changed +20.3% from the comparable as-filed period.
$6.3M→$7.6M2 prior comparisons
Shares outstanding decreased 0.7%
Shares outstanding changed -0.7% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
28,168,223→27,971,6868 prior comparisons
SBC / revenue moved 10 bp higher
SBC / revenue changed +10 basis points from the comparable as-filed period.
0.96%→1.06%2 prior comparisons
Selling, general & administrative increased 7.7%
Selling, general & administrative changed +7.7% from the comparable as-filed period.
$48.1M→$51.8M2 prior comparisons
Operating cash flow increased 9.1%
Operating cash flow changed +9.1% from the comparable as-filed period.
$148.5M→$162.0M3 prior comparisons
Current liabilities increased 17.6%
Current liabilities changed +17.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.2B→$1.4B4 prior comparisons
Stock-based compensation decreased 26.9%
Stock-based compensation changed -26.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$6.0M→$4.3M2 prior comparisons
Free-cash-flow margin moved 408 bp lower
Free-cash-flow margin changed -408 basis points from the comparable as-filed period.
23.61%→19.52%2 prior comparisons
Free-cash-flow proxy decreased 3.0%
Free-cash-flow proxy changed -3.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$142.4M→$138.1M3 prior comparisons
Operating margin moved 18 bp lower
Operating margin changed -18 basis points from the comparable as-filed period.
20.94%→20.76%2 prior comparisons
SBC / revenue moved 37 bp lower
SBC / revenue changed -37 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.99%→0.61%2 prior comparisons
Operating cash-flow margin moved 171 bp lower
Operating cash-flow margin changed -171 basis points from the comparable as-filed period.
24.62%→22.90%2 prior comparisons
Shares outstanding decreased 0.6%
Shares outstanding changed -0.6% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
28,093,026→27,911,6558 prior comparisons
Selling, general & administrative increased 3.1%
Selling, general & administrative changed +3.1% from the comparable as-filed period.
$46.7M→$48.1M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.